Opioid Use Disorder Treatment (OUDT) Course

Intended Audience:

Intended Audience: Physicians; nurse practitioners; pharmacists; counsellors; nurses

Date and Time:

See dates below.

Course Duration:

7–8 weeks

Cost:

$475

Contact Phone Number:

Please email

Contact Email:

courses.help@camh.ca

Course Overview

Description

This course will prepare learners to effectively and safely manage the treatment of clients receiving methadone or buprenorphine for opioid use disorder.  The course will also promote interprofessional collaboration among the health care team involved in the delivery of opioid dependence treatment

Pharmacists who complete this course will be in compliance with the Ontario College of Pharmacists' policy regarding required training.

Learning Objectives

• Explain the pharmacology of opioids and how they affect the brain
• Diagnose patients for opioid use disorder based on the DSM-5 criteria
• Differentiate abstinence based treatment and withdrawal management from opioid agonist treatment
• Decide on the appropriate treatment modalities for opioid use disorder based on clients' needs and clinical assessment
• Safely prescribe, does and dispense medication for opioid use disorder
• Incorporate urine drug testing into opioid agonist treatment programs
• Include counselling and case management in opioid agonist treatment
• Estabish interprofessional collaborating when providing opioid agonist treatment

Delivery Method

Online

Please note: This course requires you to use an internet browser, but the system does not support Microsoft Internet Explorer. Do not use that to access the course.

Instead, use one of the following:

·         Apple Safari

·         Google Chrome

·         Microsoft Edge

·         Mozilla Firefox

For more details, please read the browser and compatibility support page.

Thank you

Certification and Accreditation

• College of Family Physicians of Canada – Mainpro+: This Group Learning program meets the certification criteria of the College of Family   Physicians of Canada and has been certified by Continuing Professional Development, Faculty of Medicine, University of Toronto for up to 22 Mainpro+ credits.
• Royal College of Physicians and Surgeons of Canada – Section 1: This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, approved by Continuing Professional Development, Faculty of Medicine, University of Toronto.  You may claim a maximum of hours 22 (credits are automatically calculated).
• The Canadian Council on Continuing Education in Pharmacy has accredited this program for 17 CEUs.
• Le Conseil canadien de l'éducation continue en pharmacie a octroyé 17 crédits de formation continue pour ce programme.

Affiliation and Partnerships

Faculty of Medicine, University of Toronto

Register

Course start and end dates: April 19 - June 28, 2021

Please select the link below to register:

https://app.certain.com/profile/3237316

Course start and end dates:  June 14 - August 23, 2021

Please select the link below to register:

https://app.certain.com/profile/3237354

Please review the cancellation policy

Relevant Links and Resources

Recommended texts

Please note:  These are not included in course fees.  You can purchase the CAMH publications at http://store.camh.ca

For all course participants:

• Making the Choice, Making it Work - Treatment for Opioid Addiction
• The CPSO Methadone Maintenance Treatment Program Standards and Clinical Guidelines 2011.  Available: https://www.cpso.on.ca/admin/CPSO/media/Documents/physician/your-practice/quality-in-practice/assessments/mmt-guidelines.pdf

For pharmacists:

• Opioid Agonist Maintenance Treatment: A Pharmacist's Guide to Methadone and Buprenorphine for Opioid Use Disorders, published by CAMH
• OCP Opioid Policy